Carl Zeiss Meditec AG Stock Börse Stuttgart
Equities
AFXA
US14218T1051
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
90.5 EUR | -0.55% | -2.69% | -7.18% |
May. 23 | Goldman downgrades Carl Zeiss Meditec to 'Sell' - Target 90 euros | DP |
May. 23 | CARL ZEISS MEDITEC AG : Downgraded from Neutral to Sell by Goldman Sachs | ZD |
Sales 2024 * | 2.23B 2.42B | Sales 2025 * | 2.51B 2.72B | Capitalization | 8.26B 8.96B |
---|---|---|---|---|---|
Net income 2024 * | 255M 277M | Net income 2025 * | 316M 343M | EV / Sales 2024 * | 3.88 x |
Net Debt 2024 * | 396M 429M | Net Debt 2025 * | 345M 374M | EV / Sales 2025 * | 3.43 x |
P/E ratio 2024 * |
32.4
x | P/E ratio 2025 * |
26.1
x | Employees | - |
Yield 2024 * |
1.14% | Yield 2025 * |
1.3% | Free-Float | 40.86% |
Latest transcript on Carl Zeiss Meditec AG
1 week | -2.69% | ||
Current month | -7.65% | ||
1 month | -9.05% | ||
3 months | -18.47% | ||
6 months | +6.47% | ||
Current year | -7.18% |
Managers | Title | Age | Since |
---|---|---|---|
Markus Weber
CEO | Chief Executive Officer | 51 | 21-12-30 |
Director of Finance/CFO | 59 | 18-09-30 | |
Christian Müller
BRD | Director/Board Member | 57 | 09-12-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Kaschke
BRD | Director/Board Member | 66 | 01-12-31 |
Peter Kameritsch
BRD | Director/Board Member | 55 | 21-05-26 |
Heike Madan
BRD | Director/Board Member | 52 | 23-03-21 |
Date | Price | Change |
---|---|---|
24-05-24 | 90.5 | -0.55% |
24-05-23 | 91 | -2.67% |
24-05-22 | 93.5 | -0.53% |
24-05-21 | 94 | 0.00% |
24-05-20 | 94 | +1.08% |
Delayed Quote Börse Stuttgart, May 24, 2024 at 04:30 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.03% | 223B | |
+13.59% | 194B | |
+20.01% | 141B | |
+30.83% | 109B | |
+2.05% | 64.85B | |
+15.38% | 52.7B | |
+3.96% | 51.77B | |
+8.37% | 44.12B | |
+3.27% | 36.21B |
- Stock Market
- Equities
- AFX Stock
- AFXA Stock